Immunotherapies use the power of your immune system to fight your cancer. Vaccines are one form of immunotherapy. Sipuleucel-T is a vaccine used for advanced, metastatic prostate cancer if: It no ...
NCI-Led Study Shows Median PFS of 9.6 Months Results Presented at AACR Special Conference on Innovations in Prostate CancerPRINCETON, N.J., Jan.
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its ...
The immunotherapy CAN-2409 added to standard EBRT without ADT is a potential paradigm-shifting therapy for localized intermediate- to high-risk prostate cancer. CAN-2409, an adenoviral vector, plus ...
Over a median follow-up of about 50 months, men randomized to CAN-2409 plus prodrug valacyclovir had a 30% reduction in the risk for disease recurrence or death versus placebo plus valacyclovir (HR ...
News Medical on MSN
Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers
The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a ...
Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently ...
Key TakeawaysNew report shows growing use of medications, such as chemotherapy, immunotherapy, and hormone therapy, given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results